In this issue:
Ixekizumab vs adalimumab for PsA and plaque psoriasis
Patient-reported assessment of patient index data in PsA
Sustained remission in axial SpA on biological therapy
Adalimumab vs nbDMARDs for PsA
COVID-19 in patients with IMIDs
Synovitis response to secukinumab using doppler ultrasound in PsA
BSA affected by psoriasis and risk for PsA
Secukinumab and fatigue reduction in ankylosing spondylitis
Fibromyalgia and healthrelated quality of life in PsA
Aortic regurgitation and AF with radiographic axial SpA
Please login below to download this issue (PDF)